ClearPoint Neuro Inc

ClearPoint Neuro Inc

CLPT

Get informed when a big investor buys or sells

+ Follow
Market Cap$411.46M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ClearPoint Neuro IncClearPoint Neuro Inc-11.6--321%13.76.1
$21.00

Target Price by Analysts

53.1% upsideClearPoint Neuro Target Price DetailsTarget Price
$-10.27

Current Fair Value

174.8% downside

Overvalued by 174.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$411.46 Million
Enterprise Value$447.88 Million
Dividend Yield$- (-)
Earnings per Share$-0.9
Beta1.27
Outstanding Shares29,858,476

Return

Return on Equity-320.77%ROE
Return on Assets-39.85%
Return on Invested Capital-40.62%

Valuation & Multiples

P/E Ratio-11.63P/E Ratio
PEG-12.34PEG
Price to Sales13.72Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue10.59
Enterprise Value to EBIT-14.43
Enterprise Value to Net Income-13
Total Debt to Enterprise0.15
Debt to Equity6.11Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 11, 2026
EPS Estimate
$-0.27
Average shareholder expectation
Revenue Estimate
$12.73 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$-0.27
Average shareholder expectation
Revenue Estimate
$12.30 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.4118 13.90%
Total Calls626,100 86.39%
Total Puts257,800 39.35%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %46.91% 2.94%
Total Invested$249.53M 110.91%
Investors Holding140 15.00%

ESG Score

No data

About ClearPoint Neuro Inc